Mechanism of As2O3-Induced Action Potential Prolongation and Using hiPS-CMs to Evaluate the Rescue Efficacy of Drugs With Different Rescue Mechanism

Toxicological Sciences : an Official Journal of the Society of Toxicology
Meng YanBaoxin Li

Abstract

Arsenic trioxide (As2O3) has been verified as a breakthrough in the management of acute promyelocytic leukemia in recent decades. However, cardiotoxicity, especially long QT syndrome (LQTS) has become the most important issue during As2O3 treatment. The characterized mechanisms behind this adverse effect are inhibition of cardiac hERG channel trafficking and increase of cardiac calcium currents. In our study, we found a new pathway underlying As2O3-induced cardiotoxicity that As2O3 accelerates lysosomal degradation of hERG on plasma membrane after using brefeldin A (BFA) to block protein trafficking. Then we explored pharmacological rescue strategies on As2O3-induced LQTS, and found that 4 therapeutic agents exert rescue efficacy via 3 different pathways: fexofenadine and astemizole facilitate hERG trafficking via promotion of channel-chaperone formation after As2O3 incubation; ranolazine slows hERG degradation in the presence of As2O3; and resveratrol shows significant attenuation on calcium current increase triggered by As2O3. Moreover, we used human-induced pluripotent stem cell derived cardiomyocytes (hiPS-CMs) to evaluate the rescue effects of the above agents on As2O3-induced prolongation of action potential duration (APD...Continue Reading

References

May 2, 2001·The Oncologist·S Waxman, K C Anderson
Sep 18, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S L SoignetR P Warrell
Nov 13, 2001·Oncogene·T D ZhangZ Chen
Jun 24, 2004·Molecular Pharmacology·Eckhard FickerArthur M Brown
Sep 2, 2004·The Journal of Pharmacology and Experimental Therapeutics·Yuri A KuryshevDavid Rampe
May 3, 2005·Proceedings of the National Academy of Sciences of the United States of America·Igor SplawskiMark T Keating
Jan 13, 2006·Biochemical and Biophysical Research Communications·Yan ZhangBaofeng Yang
Mar 2, 2006·Molecular Interventions·Dipak K Das, Nilanjana Maulik
Jun 8, 2006·International Journal of Hematology·Kensuke NaitoKazunori Ohnishi
Mar 12, 2008·British Journal of Pharmacology·X-Y ZhaoB-F Yang
Oct 17, 2008·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Jijin LinWencan Xu
Feb 14, 2009·Circulation Research·Jianhua ZhangTimothy J Kamp
Dec 17, 2009·American Journal of Physiology. Heart and Circulatory Physiology·M SulaimanM Gupta
Jan 12, 2011·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Xichuang ChenZhimin Du
Jun 28, 2011·Trends in Molecular Medicine·Richard P DavisChristine L Mummery
Sep 18, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Dinesh PuppalaSandra J Engle
Sep 20, 2012·Physiological Reviews·Jamie I VandenbergAdam P Hill
Dec 22, 2012·Evidence-based Complementary and Alternative Medicine : ECAM·Jaroslaw DudkaMarek Murias
Nov 15, 2013·Journal of Pharmacological Sciences·Xin ZhaoBao-Xin Li
Aug 12, 2014·Naunyn-Schmiedeberg's Archives of Pharmacology·Xin ZhaoBao-Xin Li
Aug 30, 2014·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Kaiping ZhangBaofeng Yang
Nov 7, 2015·Drug Design, Development and Therapy·Meng YanBaoxin Li
Jul 7, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Ling HeRuixue Chen
Oct 21, 2016·Journal of Arrhythmia·Jennifer L SmithBrian P Delisle
Feb 12, 2017·Cell·Zhu Chen, Sai-Juan Chen

❮ Previous
Next ❯

Citations

Jan 29, 2019·Cardiovascular Research·Emily A PinheiroPaul W Burridge
Mar 26, 2021·Cell Reports Medicine·Polina MamoshinaAlfonso Bueno-Orovio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.